April 2016

DICOM Grid Announces FDA 510(k) Clearance Of Next Generation Cloud PACS And Zero-Footprint Diagnostic Viewer

Submitted by kBLASTER Team on

New York, NY – April 5, 2016 – DICOM Grid, makers of the leading cloud-based, medical image management suite, today announced FDA 510(k) clearance and new features for managing, viewing, and interpreting medical images with next generation cloud PACS and HTML 5, zero-footprint diagnostic viewer tools. To leverage these and other industry-leading...

Ekso GT Robotic Exoskeleton 510(k) Cleared for Stroke Rehab, Spinal Cord Injuries

Submitted by kBLASTER Team on

by MedGadget

Ekso Bionics (NASDAQ: EKSO) won FDA 510(k) clearance to offer its Ekso GT powered exoskeleton for rehabilitation of patients who suffer from partial paralysis caused by a stroke and for those with spinal cord injuries between levels T4 and L5 and T3 to C7. The device can provide varying amounts of assistance to one or both legs depending on the patient’s needs and what the rehab specialist is recommending.

As the patient makes steps, a rehabilitation...

Great Basin Receives FDA 510(k) Clearance for First Multiplex Panel

Submitted by kBLASTER Team on

Salt Lake City—Great Basin Scientific, Inc., (NASDAQ: GBSN) a molecular diagnostics company, has received U.S. Food & Drug Administration (FDA) 510(k) clearance for its Staph ID/R Blood Culture Panel, following submission in August 2015. The Company received notification of clearance from the FDA on March 25, 2016. This is Great Basin’s first multiplex panel to receive FDA clearance, adding to the value and versatility of the company’s analyzer, which is capable of performing...

FDA 510(k) Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use; State-of-the-Art Device Allows Individuals with Spinal Cord Injury to Stand and Walk

Submitted by kBLASTER Team on

CLEVELAND (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, announced in March 2016 that the U.S. Food and Drug Administration (FDA) has given clearance to market and sell the ...